when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Sanofi ($SNY) · news · pharmadog

← back to Sanofi

News mentioning $SNY

221 stories

Jul 13, 26Martha Lillard, last U.S. polio patient using iron lung, dies at 78 in Oklahomastat

Jul 13, 26STAT+: All eyes on data on Biogen’s tau therapystat

Jul 13, 26STAT+: Pharmalittle: We’re reading about an RFK Jr. push against psychiatric meds, a Sanofi blood cancer drug, and morestat

Jul 10, 26Hansoh meets Phase 3 SCLC goal; FDA approves Sanofi on-body injectorendpoints

Jul 8, 26Sanofi offers to end disparaging claims against CSL flu shot in Europeendpoints

Jul 6, 26Gene editing developer Scribe plots an IPObiopharma dive

Jul 1, 26FDA warns Genzyme's Irish site over quality questionsendpoints

Jun 30, 26These biotechs just landed big fundraising hauls. Here’s what they pitched to investors.biopharma dive

Jun 30, 26STAT+: Pharmalittle: We’re reading about Chinese trial sites being probed, RFK Jr. and peptides, and morestat

Jun 30, 26Sanofi’s Lumizyme successor passes Phase 3 test in babies with Pompe diseaseendpoints

Jun 29, 26STAT+: AstraZeneca to pay $34 million to settle kickback charges filed by Texas attorney generalstat

Jun 29, 2610 clinical trials to watch in the second half of 2026biopharma dive

Jun 18, 26cAMPfield lands $180M to build gut disease drugbiopharma dive

Jun 18, 26Biogen adds more immune drugs in $1B buyout of secretive startup RayTherabiopharma dive

Jun 18, 26RA, Forbion and Sanofi Ventures appear to back new eye drug from Koreaendpoints

Jun 18, 26Kardigan extends biotech’s streak of big IPOs with $400M haulbiopharma dive

Jun 17, 26RFK Jr. presents $700 million in mental health funding, but experts say grants aren’t newstat

Jun 17, 26STAT+: Advocacy groups petition FDA to withdraw approval of ‘unsafe’ use of antibiotics given to livestockstat

Jun 17, 26STAT+: Pharmalittle: We’re reading about hackers extorting Novo, an FDA about-face, and morestat

Jun 16, 26STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, Germany’s pricing plans, and morestat

Jun 15, 26STAT+: FDA approves Colorado’s plan to import cheaper drugs from Canadastat

Jun 15, 26Gan & Lee's Phase 3 obesity successes; J&J touts multiple myeloma dataendpoints

Jun 15, 26STAT+: A key European clinical trial registry lacks complete and timely results, an analysis findsstat

Jun 15, 26STAT+: Lilly’s Ajax acquisition may have been worth itstat

Jun 15, 26STAT+: Pharmalittle: We’re reading about Pfizer’s emergency penicillin program, a Sanofi diabetes drug, and morestat

Jun 15, 26STAT+: One California politician’s unexpected crusade against ultra-processed foodstat

Jun 15, 26STAT+: Amid confusion over Pfizer’s emergency penicillin program, newborn is diagnosed with preventable syphilisstat

Jun 15, 26As states follow Trump’s Medicaid fraud playbook, people with disabilities struggle to find carestat

Jun 13, 26STAT+: FDA approves Sanofi diabetes drug for children with stage 3 diabetesstat

Jun 12, 26STAT+: Up and down the ladder: The latest comings and goingsstat

← prevpage 6 of 8next →